Biotec BetaGlucans is the market leader in the areas of yeast beta-1,3/1,6-glucans used as immunomodulators in medical devices, especially in wound treatment.
The company is heavily R&D-focused and has its own pharma-approved manufacturing plant in Norway, and its ingredients are supported by more than 60 publications and studies.
It is now re-entering the nutrition market with its M-Gard product range. The portfolio consists of a particulate product with at least 75% beta-1,3/1,6-glucan content - effective at daily dosages of as low as 250mg; a high-grade glucan product with at least 85% beta-1,3/1,6- glucan content; and a suspension with 5% dry glucan matter content.
Typical applications for these ingredients include capsules, gummy bears, liquid shots, bars, post-work-out recovery products and chewing gum.
Nutritional applications concern compromised immune systems, and may include prevention of viral and bacterial infections, improving overall physical health, protecting in periods of exceeded stress and support of respiratory health, and allergy prevention.
The flagship product, M-Gard particulate - based on a volume-depending pricing model - has an indicative price of $150/kg from Biotec's US east coast hub in Philadelphia, or its production facility in Norway.
In case of high volumes, the company can offer additional discounts. Based on present knowledge, the price quoted for each serving is lower than any other comparable yeast beta-1,3/1,6-glucan technology.